UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): Jume 30, 2003
APPLIED DNA SCIENCES, INC.
------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 2 90519 59-2262718
------ ------- ----------
(State or other jurisdiction Commission (IRS Employer
of Incorporation) File Number Identification No.)
9225 Sunset Boulevard Los Angeles, CA 90069
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (310) 860-1362
(Former name or former address, if changed since last report.)
Item 5. Other Information
On or about June 9, 2003, Applied DNA Sciences, Inc. ("the Company") made a
repurchase of 7,500,000 shares of its common stock by partially exercising its
option with Glenn Little, the former president of ProHealth Medical
Technologies, Inc. Subsequent to the Company's reorganization in October of
2002, Glenn Little granted a one year option to the Company to purchase
8,500,000 common shares held in his name for $100,000. For the Company's partial
exercise, Glenn Little accepted a convertible promissory note in the amount of
$88,500. On June 30, 2003 the Company returned the shares to its stock transfer
agent for cancellation. Glenn Little disclosed the transaction and his
disposition of shares on a Form 4.
The number of shares issued and outstanding as a result of this transaction is
16,936,722.
Exhibit
-------
99.3 Promissory Note.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
APPLIED DNA SCIENCES, INC.
/s/ Gerhard H. Wehr
------------------------------
Gerhard H. Wehr
Chief Financial Officer